Regulatory News:
NeuroVive Pharmaceutical AB (STO:NVP):
The shareholders of NeuroVive Pharmaceutical AB (publ), corporate identity number 556595-6538, are hereby convened to the Annual General Meeting, held at 4 p.m. on Monday, 30 March 2015 at Medicon Village, Scheelevägen 2, Lund, Sweden, with admission for registration from 3:30 p.m.
Help employers find you! Check out all the jobs and post your resume.
